Emerging MEK inhibitors
Year: 2010
Type: review
Source: Expert Opinion on Emerging Drugs
Institutions: East Carolina University, Instituto Nazionale Tumori Regina Elena, Sapienza University of Rome, University of Parma, Ospedale di Parma, University of Catania, University of Bologna, University of Palermo, Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy, National Research Council
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: U.S. Public Health Service
Award: G3509830000
OpenAlex ID: W2134295475
